Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-23A Phase 1/2 Open-label, Multicenter Study of Oral GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-20A Pilot Feasibility Study of a Culturally Adapted Partnered Strength Training Intervention for Hispanic Cancer Survivors and Their Caregivers
-
CLINICAL_TRIALS study record update · 2026-03-20Clinical, Epidemiologic, and Genetic Studies of Li-Fraumeni Syndrome
-
CLINICAL_TRIALS study record update · 2026-03-19A Phase 1, Open-Label Study of ABSK021 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2026-03-19Machine Learning Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER-2-Targeted Therapies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-19Anatomical-Clinical Base of Adenocarcinoma Pancreatic
-
CLINICAL_TRIALS study record update · 2026-03-17A Phase 1 Study of a Selective AKT1 E17K Allosteric Inhibitor, ATV-1601, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-13An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2026-03-12VICTORIE (VTE In Cancer - Treatment, Outcomes and Resource Use In Europe)
-
CLINICAL_TRIALS study record update · 2026-03-11SUPR-3D: A Randomized Phase III Trial Comparing Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases
-
CLINICAL_TRIALS study record update · 2026-03-09Improving Surveillance of Women With Personal History of Breast Cancer Using Contrast-Enhanced Mammography (CEM)
-
CLINICAL_TRIALS study record update · 2026-03-05The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase III, Randomized, Open-Label Study of Pralsetinib Versus Standard of Care for First-Line Treatment of RET Fusion-Positive, Metastatic Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2026-03-04Effects on Anxiety and Depression of a Lay-led Transdiagnostic Self-management Program (ADSMP-C) for Patients Recently Treated for Cancer With Curative Intent: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-04Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells
-
CLINICAL_TRIALS study record update · 2026-03-03An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors
-
CLINICAL_TRIALS study record update · 2026-03-03Long-Term Follow-Up (LTFU) of Participants Treated With ADP Adoptive Cell Therapies
-
CLINICAL_TRIALS study record update · 2026-02-27Effect of a Mobile Application System Using the Patient Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to Improve Patients' Participation in Symptom Management During Cancer Treatment.
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 1 Safety and Efficacy Study of JV-394 Autologous Anti-CD94 Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed or Refractory CD94+ T/NK Cell Neoplasms
-
CLINICAL_TRIALS study record update · 2026-02-23FIRST-IN-HUMAN (FIH), OPEN-LABEL, PHASE 1 DOSE ESCALATION AND EXPANSION STUDY DESIGNED TO EVALUATE THE SAFETY, TOLERABILITY, PK, PD, AND PRELIMINARY CLINICAL ACTIVITY OF PF-07826390 AS A SINGLE AGENT OR IN COMBINATION TREATMENT FOR PARTICIPANTS WITH ADVANCED SOLID TUMORS.
-
CLINICAL_TRIALS study record update · 2026-02-20A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
-
CLINICAL_TRIALS study record update · 2026-02-18A Phase Ia/Ib, Open Label, Dose-escalation Study of the Combination of BI 907828 (Brigimadlin) With BI 754091 (Ezabenlimab) and BI 754111 and the Combination of BI 907828 (Brigimadlin) With BI 754091(Ezabenlimab) Followed by Expansion Cohorts, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-18Development of a Culturally Tailored Digital Resilience-Building Intervention for East Asian Immigrants With Cancer to Facilitate Advance Care Planning Discussions
-
CLINICAL_TRIALS study record update · 2026-02-17Phase 1 Study With Dose Expansion of the Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
-
CLINICAL_TRIALS study record update · 2026-02-17A Phase 1 Study of JNJ-70218902, a T Cell Redirecting Agent, in Advanced Stage Solid Tumors